학술논문

Key oncologic pathways inhibited by Erinacine A: A perspective for its development as an anticancer molecule
Document Type
article
Source
Biomedicine & Pharmacotherapy, Vol 160, Iss , Pp 114332- (2023)
Subject
Erinacine A
Cancer signalling pathways
Anticancer mechanisms
Apoptosis
Therapeutics. Pharmacology
RM1-950
Language
English
ISSN
0753-3322
Abstract
In the modern era, cancer can be controlled by chemotherapy treatment, and in many situations a stable disease is obtained. The significant clinical success and subsequent commercialization of naturally derived molecules have further encouraged their exploration as adjunctive therapies in cancer management. The purpose of this comprehensive review is to update the anticancer mechanisms triggered by Erinacine A and regulation of signaling pathways potentially involved in its anticancer activity.The results of preclinical research showed that Erinacin A, a therapeutically important biological metabolite isolated from the basidiomycete fungus Hericium erinaceus offers a multitude of possible chemotherapeutic applications by regulating complex signaling pathways as validated by various pharmacological in vitro and in vivo studies. As a result of Erinacin A's action on oncological signaling pathways, it resulted in induction of apoptosis, reduction of proliferation, invasiveness, generation of oxidative stress and cell cycle arrest in cancer cells.